DALLAS, April 25, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc. (“Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company, today announced the…
Nexeon MedSystems Appoints Wes Dittmer, CPA to Board of Directors
Taglich Brothers Initiates Nexeon Medsystems Inc.
NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) — Taglich Brothers, Inc. announces that it has initiated coverage of Nexeon Medsystems…
Nexeon’s neurotechnology in the fight against our aging bodies
We haven’t even come close to solving the problem of an aging population, so the tech sector is stepping in.…
Nexeon MedSystems Provides Shareholder Update
Company to Host Conference Call November 20, 2017 4pm CST DALLAS, Nov. 20, 2017 /PRNewswire/ — Nexeon MedSystems Inc. (OTCQB:…
Nexeon Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator
Feasibility Study is First Phase of €3.4M BioWin Award LIEGE, Belgium, Oct. 25, 2017 /PRNewswire/ — Nexeon MedSystems Inc (OTCBB: NXNN)…
Nexeon MedSystems Goes Public, Receives Innovation Grants
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems. As Nexeon MedSystems Inc.…
Nexeon MedSystems Begins Trading as NXNN
DALLAS, Sept. 28, 2017 /PRNewswire/ — Nexeon MedSystems, Inc. (OTC:QB NXNN) announced today that it has commenced “regular way” trading on…
Nexeon MedSystems “OTCQB:NXNN” Acquires Belgian Manufacturer
Additional capacity will support Company’s current commercial product manufacturing needs LIEGE, Belgium, Sept. 6, 2017 /PRNewswire/ — Nexeon MedSystems (“Nexeon” or “the…